🎈 Up Big Today: Find today's biggest gainers with our free screenerTry Stock Screener

Needham names Stryker top pick for 2025 on new products, margin gains

Published 12/12/2024, 18:20
© Reuters
SYK
-

Investing.com -- Needham analyst named Stryker Corporation (NYSE:SYK) its top pick for 2025, highlighting growth potential from new products, margin improvements, and expected M&A activity. Raised its price target on the stock to $442 from $409.

The medical device maker is poised for strong growth next year with the launch of its Pangea trauma plating system, LIFEPAK 35 monitor/defibrillator, and new shoulder and spine applications for the Mako surgical platform.

Needham also noted the company’s projection of margin improvement in 2025, with potential revenue growth fuelling upside for earnings per share.

Stryker’s plans to increase merger and acquisition activity could act as an additional catalyst, Needham said. Brokerage now values Stryker based on its 2026 earnings estimates, underscoring confidence in the company’s growth trajectory.

The brokerage added Stryker to its Conviction List, replacing Enovis Corp, which it maintains at a “buy” rating.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2024 - Fusion Media Limited. All Rights Reserved.